Roche announced the debut of the LightCycler PRO System, which is based on the established gold standard technology of previous LightCycler Systems. This innovative technology improves performance and usability while bridging the gap between...
Owl Therapeutics, a fully owned subsidiary of Gryphon Bio, announced a global license and partnership agreement with Lund, Sweden-based Abliva AB to advance Abliva's NeuroSTAT (OWL-1410) for the prevention and treatment of moderate to severe...
The pharmaceutical quality control system is projected to experience significant growth, with the market size expected to increase from USD 1.4 billion in 2022 to USD 4.5 billion by 2032.
A team of three talented B Tech (Computer Engineering) students from NMIMS School of Technology Management and Engineering (STME), Indore, Riyanshi Bariya, Vandita Pathak, and Shalom Ram, have developed a healthcare device, 'Sehat Sathi: A Smart...
The first patient has been randomized in the phase 1 REGENERATE MSA-101 clinical trial of AB-1005, a gene therapy being developed as a treatment for multiple system atrophy-parkinsonian type (MSA-P). Asklepios BioPharmaceutical, Inc. (AskBio)...
Truqap (capivasertib) by AstraZeneca has got the clearance in the United States for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker...
Swiss-based medical technology company MedAlliance has announced acquisition by Cordis for $1.13 billion. Cordis will play a pivotal role in the marketing, distribution, and global accessibility of MedAlliance's
Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application for Ganirelix Acetate injection, 250 mcg/0.5 mL single-dose prefilled syringe, to market a generic...
The government aims to grow the pharmaceutical industry by about four times to $200 billion by 2030, Arunish Chawla, secretary, department of pharmaceuticals, said. The sector should be able to achieve the target through the help of industrial...
Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) approved Augtyro (repotrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)...
, CDSCO.jpg)
